In Brief: Genzyme/IG Labs
This article was originally published in The Gray Sheet
Executive Summary
Genzyme/IG Labs: Enter agreement in principle under which Genzyme would acquire all publicly held shares of genetic testing services company IG Labs in a tax-free merger worth approximately $21 mil. According to terms of the proposed deal, public stockholders of IG Labs would receive $7 in Genzyme General Division common stock for each IG Labs share. Genzyme's General Division consists of therapeutics, diagnostic products and services, pharmaceuticals and fine chemicals...
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.